期刊文献+

冠心病患者糖耐量变化与冠状动脉病变之间的关系分析 被引量:5

Relationship between glucose tolerance changes and coronary pathological changes in patients with coronary heart disease
下载PDF
导出
摘要 目的探讨冠心病患者糖耐量变化与冠状动脉病变之间的关系。方法 200例确诊为单纯冠心病患者分为糖耐量值正常(NGT)组132例,冠心病合并糖耐量异常(IGT)组35例,冠心病合并2型DM(T2DM)组33例。全部患者均行冠状动脉造影(CAG)与口服75g葡萄糖耐量试验,对患者血糖、胰岛素以及血脂含量进行检测。冠状动脉病变程度用CAG进行分析,冠状动脉狭窄程度按照美国心脏病学会分类标准进行分类与评价。结果①NGT、IGT与DM组糖化血红蛋白(HbA1c)、空腹血糖(FBG)、餐后2小时血糖(PBG)、甘油三酯(TG)、高密度脂蛋白(HDL-C)差异有统计学意义(P<0.05),IGT组与NGT在空腹胰岛素(FINS)差异有统计学意义(P<0.05);②NGT、IGT与DM组右冠动脉(RCA)、左前降支冠状动脉(LAD)、左主干(LMT)相比,两两之间差异均具有统计学意义(P<0.05),左回旋支(LCX)、总狭窄指数以及冠状动脉远端病变方面,IGT组与DM组较NGT组,差异均具有统计学意义(P<0.05);③DM组Gensini积分为(144.32±22.90)分,IGT组为(94.29±16.83)分,NGT组(67.77±12.32)分,DM组与IGT组和NGT组比较,Gensini积分差异有统计学意义,但DM与IGT组间比较,差异无统计学意义(P>0.05)。结论冠心病糖耐量变化与冠状动脉病变间具有一定的关联性,餐后高血糖可能是冠心病发生发展的主要原因。 Objective To investigate the relationship between glucose tolerance changes and coronary pathological changes in patients with coronary heart disease.Methods The study enrolled 200 cases of patients diagnosed with simple tolerance value normal (NGT group,n=132) and coronary heart disease with impaired glucose tolerance (IGT group,n=35),the coronary heart disease group (T2DM group,n=33).All patients underwent coronary angiography(CAG) 75 g oral glucose tolerance test to detect blood glucose,insulin and lipid content.The degree of coronary artery disease on CAG analysis,classification and evaluation of the extent of coronary stenosis were classified in accordance with the were statistical differences among NGT,IGT and DM groups except hemoglobin(HbA1c),fasting blood glucose(FBG),2 hours postprandial blood glucose(PBG),triglyceride(TG) and high density lipoprotein cholosterol(HDL-C)(P〈0.05).There were significant differences between IGT and difference of right coronary artery(RCA),left anterior descending coronary artery(LAD),left main trunk(LMT) between any two of the three groups (P〈0.05).There were statistical difference of the left circumflex coronary artery(LCX),total stenosis index,and coronary artery distal lesions in the IGT score of DM group was (144.32±22.90) points,that of IGT group was (94.29±16.83)points,and that of NGT group was(67.77±12.32)points.There was statistical difference of Gensini score in the DM,IGT group by comparison with the NGT group (P〈0.01),but there was no statistical difference between the DM and the IGT group(P〉0.05).Conclusion There is correlation between glucose tolerance changes and pathological changes in patients with coronary heart disease.Postprandial hyperglycemia may be the main reason for the development of coronary heart disease.
出处 《临床荟萃》 CAS 2014年第3期305-308,共4页 Clinical Focus
关键词 冠状动脉疾病 葡糖耐量试验 高血糖症 危险因素 coronary disease glucose tolerance test hyperglycemia risk factor
  • 相关文献

参考文献11

二级参考文献82

  • 1胡大一,王领军,余金明,布艾加尔,仝其广,王锦纹,魏毅东,吴琛.踝臂指数评价高危患者下肢外周动脉病多中心临床研究[J].中国医刊,2005,40(1):36-38. 被引量:54
  • 2杨士伟,胡大一.踝臂指数对冠状动脉狭窄重程度的预测价值[J].中国医药导刊,2006,8(2):79-82. 被引量:40
  • 3Sajjadi F, Mohammadifard N, Kelishadi R. et al .Clustering of coronary artery disease risk factors in patients with type 2 diabetes and impaired glucose tolerance [J].East Mediterr Health J, 2008,14(5):1080-1089.
  • 4Bartnik M, Malmberg K, Hamsten A, et al. Abnormal glucose tolerance--a common risk factor in patients with acute myocardial infarction in comparison with population-based controis[J]. J Intern Med, 2004, 256(4):285-297.
  • 5Wallace TM, Matthews DR. The assessment of insulin resistance in man[J]. Diabet Med, 2002,19(7):527-534.
  • 6Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardiol, 1983,51(3):606.
  • 7Anselmino M, Mellbin L, Wallander M, et al. Early detection and integrated management of dysglycemia in cardiovascular disease: a key factor for decreasing the likelihood of future events[J].Rev Cardiovasc Med, 2008,9(1):29-38.
  • 8Dong X, Zhou L, Zhai Y, et al. Impaired fasting glucose and the prevalence and severity of angiographic coronary artery disease in high-risk Chinese patients [J]. Metabolism, 2008,57(1):24-29.
  • 9NNilsson D, Wackenfors A, Gustafsson L, et al. PKC and MAPK signalling pathways regulate vascular endothelin receptor expression [J].Eur J Pharmacol, 2008,580 (1-2):190- 200.
  • 10Yoon YW, Kang TS, Lee BK. et al. Pathobiological role of advanced glycation ondproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy [J].Exp Mol Med, 2008,40(4):398-406.

共引文献47

同被引文献47

  • 1尹绢,寇光,邱元芝,彭乐,魏群,胡坚.伏格列波糖早期干预治疗对合并糖耐量减低老年冠心病患者的影响[J].中国老年学杂志,2014,34(2):348-350. 被引量:7
  • 2Choksy P, Davis HC, Januzzi J, et al. Brain natriuretic hormone predicts stress-induced alterations in diastolic function[J].Am J Med Sci,2014,348(5) :366-370.
  • 3Alraies MC, Kusunose K, Negishi K, et a[. Relation hetween echocardiographically estimated and invasively measured filling pressures in constrictive pericarditis[J].Am J Cardiol, 2014,113(11):1911-1996.
  • 4Gokce S, Atbinici Z, Ayean Z, et al. The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children[ J]. Pediatr Cardiol, 2013,34(2) :308-315. DOI: 10. 1007/s00246- 012-0447-9.
  • 5Irie Y, Katakami N, Kaneto H, et al. Maximum carotid intimamedia thickness improves the prediction ability of coronary artery stenosis in type 2 diabetic patients without history of coronary artery disease[ J]. Atherosclerosis,2012,221 (2) :438-444. DOI : 10. 1016/j. atherosclerosis. 2012.01. 022.
  • 6Uematsu M, Nakamura T, Sugamata W, et al. Echolucency of carotid plaque is useful for assessment of residual cardiovascular risk in patients with chronic coronary artery disease who achieve LDL-C goals on statin therapy[J]. Circ J,2014,78 ( 1 ) : 151-158.
  • 7GOKCE S, ATBINICI Z. The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children [ J]. Pediatr Cardiol, 2012, 9(1): 60-80.
  • 8IRIE Y, KATAKAMI N, KANETO H, et al. Maximum carotid intima-media thickness improves the prediction ability of coronary artery stenosis in type 2 diabetic patients without history coronary artery disease [J]. Athemselemsis, 2012, 221 (2) : 438-444.
  • 9UEMATSU M, NAKAMURA T, SUGAMATA W, et al. Echolucency of carotid plaque is useful for assessment of residual cardiovascular risk in patients with chronic coronary artery disease who achieve LDL-C goals on statin therapy[J]. Circ J, 2013, 78(1) : 151-158.
  • 10智宏,任利群,马根山,冯毅,叶行舟,刘乃丰.冠心病合并代谢综合征者炎症因子水平与冠脉病变程度的研究[J].东南大学学报(医学版),2009,28(1):10-12. 被引量:24

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部